MedPath

A clinical trial to assess the combined effect of two drugs, Yogaraj Rasayana and Dhatri Loha in patients of Pandu (Iron Deficiency Anaemia)

Phase 2
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2024/01/061727
Lead Sponsor
Vd Neeraja Satish Kulkarni
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients of Pandu between age group of 16 to 50 years of either gender 2) Patients having lakshanas such as Panduta, Akshikuta Shoth, Hrutspandan, Shishirdwesha, Aarohan Ayas, Shrama, Bhrama and Daurbalya 3) Patients suffering from mild and moderate Iron deficiency Anaemia according to WHO having Hb% as follows - Males mild - 11.0 to 12.9 gm% Moderate - 8.0 to 10.9gm%

Females - mild - 11.0 to 11.9 gm% Moderate - 8.0 to 10.9 gm%

Exclusion Criteria

1) Anaemia due to blood loss - repeated miscarriages, at menarche, post-menopausal, through other orifices and GIT due to bleeding piles, malignancies etc. 2) Pregnancy and lactation 3) All types of Anaemia other than Iron Deficiency Anaemia 4) Other major systemic diseases like Diabetes Mellitus, Hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rise in Hb%.Timepoint: at baseline and after 90 days (after the treatment)
Secondary Outcome Measures
NameTimeMethod
Clinical symptoms will be assessed.Timepoint: at baseline, 15th day, 30th day, 45th day, 60th day, 75th day, 90th day.
© Copyright 2025. All Rights Reserved by MedPath